Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02391272Phase 3Completed
A Phase 3 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP), sponsored by Shandong University. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02391272.